drugset / Trial / NCT00574067

Buprenorphine for Prisoners

NCT00574067

RandomizedParallel-groupOpen-labelHealth-services research

Summary

This five-year study examines the effectiveness of buprenorphine treatment provided to previously-addicted inmates(N=320; 160 males, 160 females) initiated in prison and continued in the community. The study also examines the extent to which the setting of post-release buprenorphine is provided.It is expected that participants receiving in-prison buprenorphine will have superior outcomes compared to participants who did not receive in-prison buprenorphine.

Timeline

Start
2008-09
Primary completion
2013-03
Completion
2013-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified 32 mg
Subject Buprenorphine Other / unclassified 48 mg

Indications